Why the study?
Immediate access to 12-lead ECGs is not always possible, creating a need to evaluate and identify high-quality portable ECG options based on statistical data, mechanical qualities, price, and tech features.
This review provides a comparison of portable ECG devices to help consumers make educated purchasing decisions based on statistical data, features, and price.
Answers are grounded in this paper and cite their sources.
May guide portable ECG selection for ambulatory monitoring; leaves open prospective clinical validation trials.
Electrocardiograms (ECGs) are devices that measure the heart’s electrical activity. ECGs have shown to identify issues with a person’s heart. It is quite well known that heart disease has been a leading cause of death. Using ECGs for those who have heart issues is crucial for preventing serious implications, but it’s not always possible to have immediate access to a 12-lead ECG used in healthcare facilities. For this reason, it’s important to have a portable ECG that suits the user’s needs. In the status quo, there are many portable ECGs with splendid features offered. However, a deeper dive into the categories of statistical data, mechanical qualities, price, and tech features of these ECGs reveals that we can reduce the number of high-quality portable ECG options available to a select few. Over 10 devices were identified originally. However, the number was reduced to 8 as only those had statistical data. Devices that did not have information about a subcategory or category were excluded in the analysis of identifying the best ECG for their respective categories. The study concluded with identifying AliveCor Kardia Mobile SL as the “winner” of the 8 ECG lineup, with the Microlife WatchBP Home A and AliveCor Kardia Mobile 6L devices following in second and third places, respectively. In conclusion, this study allows the consumer to make an educated decision, based on their preferences, which ECG would suit best for him/her. Keywords: Preventive Care, Heart Disease, EKG, ECG, Portable, Sensitivity, Specificity, Price
No takes yet. Share an insight, caveat, or question.
Chellarapu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: